{
  "story_id": "a51c2dd031a0768fb807f1dc597ea5f9",
  "desk": "drm3",
  "revision": 1,
  "published_at": "2026-09-04T00:09:24.382Z",
  "content_hash": "e222590dbb1b6ee4559f3134b75941faf7c547b4a3ecaec8860321ffb00cb92c",
  "hash_basis": "sha256 over `headline\\ndek\\nprose`, plus `\\n` + the canonical citations JSON when any source is placed, plus `\\n#blog` for blogs",
  "basis": {
    "headline": "Kim Seung-won Accused of Bribery, Judicial Bias, and Party Fund Scandal",
    "dek": "Prosecutors allege Kim Seung-won sought drug approval favors and had improper ties to the judge overseeing the warrant review.",
    "prose": "Prosecutors filed an indictment on 2024-12-03 charging Kim Seung-won with bribery for allegedly using an intermediary to influence a Food and Drug Safety official regarding a new drug approval. [^1]\n\nKim Seung-won's inquiry team announced on 2026-04-03 that there is no evidence of him receiving political donations or gifts. [^2]\n\nSeo Young-gyo, the Chairman of the National Assembly's Legislation and Justice Committee, stated on 2026-04-04 that the clinical trial bribery allegations against Kim Seung-won appear to be typical behavior among politicians. [^3]\n\nKim Seung-won responded to the intermediary's request on 2021-10-08 with the Korean word 'Oke' (Okay) and later instructed the intermediary to ask the Food and Drug Safety official to process the matter quickly. [^4]\n\nPhotos released by the intermediary Yang in February 2022 show Kim Seung-won posing with Judge Jung, who denied the arrest warrant for the drug company founder, raising concerns about judicial bias. [^5]\n\nThe Food and Drug Safety Institute approved the clinical trial on 2021-10-17, nine days after Kim Seung-won met with the intermediary at a restaurant in Yeouido, Seoul. [^6]\n\nKim Seung-won received a suspended prosecution ruling in December 2024 regarding the bribery allegations. [^7]\n\nKim Seung-won was investigated in 2021 for soliciting expedited approval of a clinical trial for a Genentech COVID-19 treatment from then-Food and Drug Safety Institute Director Kim Kang-rim. [^8]",
    "cited": "[{\"statement\":\"Prosecutors filed an indictment on 2024-12-03 charging Kim Seung-won with bribery for allegedly using an intermediary to influence a Food and Drug Safety official regarding a new drug approval.\",\"source\":\"동아일보\",\"instrument\":\"News\",\"claim_key\":null,\"published_at\":\"2026-09-03T19:30:00.000Z\",\"publisher_count\":1,\"sources\":[\"동아일보\"]},{\"statement\":\"Kim Seung-won's inquiry team announced on 2026-04-03 that there is no evidence of him receiving political donations or gifts.\",\"source\":\"KyungHyangSinmun\",\"instrument\":\"News\",\"claim_key\":null,\"published_at\":\"2026-09-04T00:09:24.382Z\",\"publisher_count\":1,\"sources\":[\"KyungHyangSinmun\"]},{\"statement\":\"Seo Young-gyo, the Chairman of the National Assembly's Legislation and Justice Committee, stated on 2026-04-04 that the clinical trial bribery allegations against Kim Seung-won appear to be typical behavior among politicians.\",\"source\":\"KyungHyangSinmun\",\"instrument\":\"News\",\"claim_key\":null,\"published_at\":\"2026-09-04T00:09:24.382Z\",\"publisher_count\":1,\"sources\":[\"KyungHyangSinmun\"]},{\"statement\":\"Kim Seung-won responded to the intermediary's request on 2021-10-08 with the Korean word 'Oke' (Okay) and later instructed the intermediary to ask the Food and Drug Safety official to process the matter quickly.\",\"source\":\"동아일보\",\"instrument\":\"News\",\"claim_key\":null,\"published_at\":\"2026-09-03T19:30:00.000Z\",\"publisher_count\":1,\"sources\":[\"동아일보\"]},{\"statement\":\"Photos released by the intermediary Yang in February 2022 show Kim Seung-won posing with Judge Jung, who denied the arrest warrant for the drug company founder, raising concerns about judicial bias.\",\"source\":\"동아일보\",\"instrument\":\"News\",\"claim_key\":null,\"published_at\":\"2026-09-03T19:30:00.000Z\",\"publisher_count\":1,\"sources\":[\"동아일보\"]},{\"statement\":\"The Food and Drug Safety Institute approved the clinical trial on 2021-10-17, nine days after Kim Seung-won met with the intermediary at a restaurant in Yeouido, Seoul.\",\"source\":\"동아일보\",\"instrument\":\"News\",\"claim_key\":null,\"published_at\":\"2026-09-03T19:30:00.000Z\",\"publisher_count\":1,\"sources\":[\"동아일보\"]},{\"statement\":\"Kim Seung-won received a suspended prosecution ruling in December 2024 regarding the bribery allegations.\",\"source\":\"KyungHyangSinmun\",\"instrument\":\"News\",\"claim_key\":null,\"published_at\":\"2026-09-04T00:09:24.382Z\",\"publisher_count\":1,\"sources\":[\"KyungHyangSinmun\"]},{\"statement\":\"Kim Seung-won was investigated in 2021 for soliciting expedited approval of a clinical trial for a Genentech COVID-19 treatment from then-Food and Drug Safety Institute Director Kim Kang-rim.\",\"source\":\"KyungHyangSinmun\",\"instrument\":\"News\",\"claim_key\":null,\"published_at\":\"2026-09-04T00:09:24.382Z\",\"publisher_count\":1,\"sources\":[\"KyungHyangSinmun\"]}]",
    "kind": "news"
  },
  "receipt_verify": "Ed25519 over the dot-joined string `slice_hash.cursor_from.cursor_to.view.view_version.row_count`; public_key and sig are base64url of the raw 32-byte key / 64-byte signature",
  "receipt": null,
  "receipt_note": "this revision predates receipt-keeping (before v0.37.0); the filed row lives in the record",
  "generation_chain": {
    "wire": {
      "stream": "fountain_news",
      "story_id": "e0ebf2bcde1649a336f8fa8d07dc2c1b",
      "thread_id": "53de00df9fe53e1d2edb4930c7264871",
      "thread_label": "Food and Drug Safety Institute",
      "novelty": "UPDATE",
      "content_hash": "f429901122f45255e048ef7ab8423c3cbf429571aee92ebf0a1625ecea0f37b6",
      "last_published_at": "2026-09-04T00:09:24.382Z",
      "read_receipt": {
        "slice_hash": "7832ff481a11463b2093f559e599c74ec5bf17fa6792bf578b65efa1a8a4140c",
        "cursor_from": "eyJ0cyI6IjIwMjYtMDktMDNUMjM6Mzk6MTEuMDAwMDAwWiIsImlkIjoiYWQxYzcyNWZjNWY1NzBhMGEzOTJiNjI4ZjU2MDhjNzciLCJ2IjoiMSJ9",
        "cursor_to": "eyJ0cyI6IjIwMjYtMDktMDRUMDA6MTk6MzkuMDAwMDAwWiIsImlkIjoiMmRhNzQxN2Y3NDBlZjMwYTM1ODc0MjUyYTRjMGY2MzEiLCJ2IjoiMSJ9",
        "view": "v_fountain_news",
        "view_version": "1",
        "row_count": 100,
        "window_days": 3,
        "bytes_scanned": 12166856,
        "credits": 8,
        "price_per_100_rows": 8,
        "sig": "i5BjhIWuGVkgCTwwTBHv6lG2N7_Pyetrzb1J62W0XtkLqPKusyMJt8bRsaLFbDUBVF_djjS25TqZKQSy3camAg",
        "public_key": "bMUigy8O0jOnBxQ4Sc-5lwhIZ8LQVAhxMbR7qESVuUE",
        "signer_path": "lakehouse/data-extract/v1",
        "alg": "Ed25519",
        "signed": true
      }
    },
    "written_at": "2026-09-04T06:51:48.524Z"
  },
  "cited_facts": [
    {
      "statement": "Prosecutors filed an indictment on 2024-12-03 charging Kim Seung-won with bribery for allegedly using an intermediary to influence a Food and Drug Safety official regarding a new drug approval.",
      "source": "동아일보",
      "instrument": "News",
      "claim_key": null,
      "published_at": "2026-09-03T19:30:00.000Z",
      "publisher_count": 1,
      "sources": [
        "동아일보"
      ]
    },
    {
      "statement": "Kim Seung-won's inquiry team announced on 2026-04-03 that there is no evidence of him receiving political donations or gifts.",
      "source": "KyungHyangSinmun",
      "instrument": "News",
      "claim_key": null,
      "published_at": "2026-09-04T00:09:24.382Z",
      "publisher_count": 1,
      "sources": [
        "KyungHyangSinmun"
      ]
    },
    {
      "statement": "Seo Young-gyo, the Chairman of the National Assembly's Legislation and Justice Committee, stated on 2026-04-04 that the clinical trial bribery allegations against Kim Seung-won appear to be typical behavior among politicians.",
      "source": "KyungHyangSinmun",
      "instrument": "News",
      "claim_key": null,
      "published_at": "2026-09-04T00:09:24.382Z",
      "publisher_count": 1,
      "sources": [
        "KyungHyangSinmun"
      ]
    },
    {
      "statement": "Kim Seung-won responded to the intermediary's request on 2021-10-08 with the Korean word 'Oke' (Okay) and later instructed the intermediary to ask the Food and Drug Safety official to process the matter quickly.",
      "source": "동아일보",
      "instrument": "News",
      "claim_key": null,
      "published_at": "2026-09-03T19:30:00.000Z",
      "publisher_count": 1,
      "sources": [
        "동아일보"
      ]
    },
    {
      "statement": "Photos released by the intermediary Yang in February 2022 show Kim Seung-won posing with Judge Jung, who denied the arrest warrant for the drug company founder, raising concerns about judicial bias.",
      "source": "동아일보",
      "instrument": "News",
      "claim_key": null,
      "published_at": "2026-09-03T19:30:00.000Z",
      "publisher_count": 1,
      "sources": [
        "동아일보"
      ]
    },
    {
      "statement": "The Food and Drug Safety Institute approved the clinical trial on 2021-10-17, nine days after Kim Seung-won met with the intermediary at a restaurant in Yeouido, Seoul.",
      "source": "동아일보",
      "instrument": "News",
      "claim_key": null,
      "published_at": "2026-09-03T19:30:00.000Z",
      "publisher_count": 1,
      "sources": [
        "동아일보"
      ]
    },
    {
      "statement": "Kim Seung-won received a suspended prosecution ruling in December 2024 regarding the bribery allegations.",
      "source": "KyungHyangSinmun",
      "instrument": "News",
      "claim_key": null,
      "published_at": "2026-09-04T00:09:24.382Z",
      "publisher_count": 1,
      "sources": [
        "KyungHyangSinmun"
      ]
    },
    {
      "statement": "Kim Seung-won was investigated in 2021 for soliciting expedited approval of a clinical trial for a Genentech COVID-19 treatment from then-Food and Drug Safety Institute Director Kim Kang-rim.",
      "source": "KyungHyangSinmun",
      "instrument": "News",
      "claim_key": null,
      "published_at": "2026-09-04T00:09:24.382Z",
      "publisher_count": 1,
      "sources": [
        "KyungHyangSinmun"
      ]
    }
  ],
  "note": "A signature proves who filed this and that it has not changed since. It never makes a claim true."
}